#316 - AMA #63: A guide for hair loss: causes, treatments, transplants, and sex-specific considerations
Host Peter Attia and co-host Nick Stenson discuss hair loss, focusing on androgenic alopecia, its causes, and impact on quality of life. They cover various treatments like minoxidil, finasteride, laser therapy, and PRP, along with hair transplantation.
Deep Dive Analysis
14 Topic Outline
Introduction to AMA #63 and hair loss overview
Hair loss as a factor in healthspan and quality of life
Defining androgenic alopecia (AGA) as the main focus
Distinguishing hair loss patterns and etiologies in men vs. women
Overview of various hair loss treatments to be discussed
Peter's personal experience with shaving his head
Emotional impact of hair loss on quality of life
Prevalence of hair loss in men and women
Differentiating AGA from other causes of hair loss
Genetic and hormonal basis of androgenic alopecia
The role and potency of dihydrotestosterone (DHT) in hair loss
Visual differences in male and female hair loss patterns
Importance of consulting a specialist for hair loss diagnosis
Early detection and risk assessment for androgenic alopecia
4 Key Concepts
Androgenic Alopecia (AGA)
The most common form of hair loss, responsible for about 95% of hair loss in men and at least half in women, characterized by genetic susceptibility of hair follicles to hormones, primarily dihydrotestosterone (DHT).
Dihydrotestosterone (DHT)
A more potent derivative of testosterone, formed by the enzyme 5-alpha reductase, which binds to androgen receptors on genetically susceptible hair follicles, leading to a process of miniaturization and gradual thinning of the hair shaft over time.
Androgen Receptor (AR)
The specific receptor that hormones like testosterone and dihydrotestosterone (DHT) bind to in order to exert their effects. DHT has a much higher binding affinity for the androgen receptor compared to testosterone.
Hair Follicle Miniaturization
A process where genetically susceptible hair follicles, when exposed to dihydrotestosterone (DHT), gradually shrink over time. This results in the production of finer, shorter hairs, eventually leading to visible hair thinning and loss.
6 Questions Answered
Androgenic alopecia is the most common form of hair loss, accounting for about 95% of male hair loss and at least half of female hair loss, driven by genetic susceptibility of hair follicles to hormones like DHT.
Male pattern hair loss affects 30% to 50% of men by age 50, while female pattern hair loss affects 20% to 50% of women over their entire lifespan.
Androgenic alopecia is primarily caused by a genetic susceptibility of hair follicles combined with exposure to hormones, most notably dihydrotestosterone (DHT), which leads to follicle miniaturization.
DHT is a potent hormone derived from testosterone that binds with high affinity to androgen receptors on hair follicles. In genetically susceptible individuals, this binding causes hair follicles to shrink, leading to thinner, shorter hairs and eventual hair loss.
In men, hair loss typically occurs in the temporal region and on the top of the head, following a specific scale. In women, it's often more diffuse, starting with a widening of the part and thinning at the top of the scalp, with less likelihood of significant balding.
While AGA is common, it's always recommended to consult a multidisciplinary hair center or specialist to rule out other potential causes of hair loss, such as autoimmune conditions, nutritional deficiencies (e.g., iron, vitamin D, B12), or certain medications, which can sometimes mimic AGA.
4 Actionable Insights
1. Consult Hair Loss Specialist
If experiencing hair loss, consult a multidisciplinary hair center or specialist to evaluate and rule out all potential causes, as some non-genetic causes can resemble androgenic alopecia (AGA). This ensures proper diagnosis and treatment.
2. Rule Out Non-AGA Causes
If experiencing hair loss, especially for women, consider and rule out temporary causes like pregnancy, post-pregnancy thinning, autoimmune conditions, significant psychological stress, hormonal changes (menopause), and deficiencies in iron, vitamin D, or B12. Also, be aware of rare medication-related hair loss from statins, antidepressants, or certain antihypertensives.
3. Manage Testosterone & DHT
Be aware that taking supplemental testosterone can increase dihydrotestosterone (DHT) levels, which may accelerate hair loss in individuals genetically predisposed to androgenic alopecia, unless medications are used to block the conversion of testosterone to DHT.
4. Hair Loss Impacts Emotional Health
Recognize that hair loss, by causing distress, can impair an individual’s quality of life and emotional health, thus fitting into the broader concept of healthspan. This perspective can validate the importance of addressing hair loss concerns.
3 Key Quotes
While hair loss is not a direct threat to lifespan, of course, it certainly can be a relatable topic when speaking about aging, and one could certainly make the case that it factors into healthspan and quality of life.
Peter Atiyah
genetic sensitivity to DHT appears far more important than absolute DHT level.
Peter Atiyah
DHT, DHT binding to hair follicles will actually lead to this process of miniaturization.
Peter Atiyah